Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11281-11286
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11281
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11281
Table 1 Selected pegylated interferon/ribavirin treatment trials in children with chronic hepatitis C infection n (%)
| Ref. | n | Treatment | Sustained virological response | ||
| All types | HCV type 1 | HCV type 2/3/6 | |||
| Wirth et al[26] | 41 | IFN-2b-ribavirin | 25 (61) | 18 (53) | 7 (100) |
| González-Peralta et al[25] | 118 | IFN-2b-ribavirin | 54 (46) | 33 (36) | 21 (84) |
| Wirth et al[27] | 62 | PEG-IFN-2b-ribavirin | 36 (59) | 22 (48) | 13 (100) |
| Wirth et al[28] | 107 | PEG-IFN-2b-ribavirin | 70 (65) | 38 (53) | 28 (93) |
| Schwarz et al[29] | 55 | PEG-IFN-2a-ribavirin | 29 (53) | 21 (47) | 8 (80) |
| Schwarz et al[29] | 59 | PEG-IFN-2a | 12 (21) | 8 (17) | 4 (36) |
- Citation: Khaderi S, Shepherd R, Goss JA, Leung DH. Hepatitis C in the pediatric population: Transmission, natural history, treatment and liver transplantation. World J Gastroenterol 2014; 20(32): 11281-11286
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11281.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11281